ASXBlog

Outlook for Australian shares in 2021

Emma Fisher, Airlie Funds Management

Three key factors to consider when choosing companies next year.

7 key trends for global equities next year 

Andrew Clifford, Platinum Asset Management

Inflation, government spending and US dollar top the list of what to watch.

3 investment issues for 2021 and beyond

Vera Lin, Ord Minett

Ord Minnett advisers Vera Lin, Alison Kolb and Phillip Lucas discuss asset allocation, yield and diversification.

Three investing megatrends and the ETFs to watch in 2021

Sarah Hare, BetaShares

BetaShares’ Sarah Hare considers artificial intelligence; VanEck’s Arian Neiron examines video gaming; and ETF Securities’ Kanish Chugh looks at technology.

Listed investment companies appeal for income investors

Ian Irvine, Listed Investment Companies & Trusts Association

Sector shows its worth for investors in times of sharemarket volatility.

Hybrids offer diversification, income opportunities in 2021

Cameron Duncan, Shaw and Partners

Sharemarket volatility strengthens the case to consider hybrids in portfolios.

Resources and Tech lead charge for ASX IPOs 

Josh Collard, ASX

Secondary capital raisings have started to make way for IPOs as companies are dusting off deferred IPO plans to take advantage of current market conditions

Get to know ASX’s new public company: Aroa Biosurgery

Blair Harrison, ASX

Aroa Biosurgery (ASX: ARX) is ASX’s 57th New Zealand IPO and listed with a market capitalisation of $225 million

The Times They Are A Changin’: ASX Emerging as a Force for Tech and its Stakeholders

Richard Horton, Squire Patton Boggs

ASX as a truly robust fundraising and exit platform for mid-stage technology startups both locally and globally represents a remarkable achievement for the ASX in the world of tech

The changing face of capital markets 

James Lee, Jarden

Investors are facing a very simple problem; increased capital for a home in what is now a significantly more volatile and complex market.